Skip to main content

Site notifications

BIOTIME SARS-CoV-2 IgG/IgM Rapid Qualitative Test

Australian sponsor
ARTG
347730
Manufacturer
Xiamen Biotime Biotechnology Co Ltd (China)
Date approved for supply
Type of test
Lateral Flow IgG/IgM
Intended use
Point-of-care test
Model/Type of use
Biotime SARS-CoV-2 IgG/IgM Rapid Qualitative Test
Evaluation report
Doherty Institute Results Report
Regulatory and other action
  • Review complete

Help us improve the Therapeutic Goods Administration site